Stereotactic body radiotherapy: an attractive treatment modality for recurrent head and neck carcinoma. (Regarding Lartigau et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer)

Affiliations

¹ Cruces University Hospital, Radiation Oncology Department, c/Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya (Basque Country), Spain. Electronic address: jon.cacicedofernandezbobadilla@osakidetza.net.
² Cruces University Hospital, Radiation Oncology Department, c/Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya (Basque Country), Spain. Electronic address: Pedro.bilbaozulaica@osakidetza.net.

Comment

Jon Cacicedo et al. Radiother Oncol. 2014 Jun.

. 2014 Jun;111(3):482-3.

doi: 10.1016/j.radonc.2014.01.028. Epub 2014 Mar 14.

¹ Cruces University Hospital, Radiation Oncology Department, c/Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya (Basque Country), Spain. Electronic address: jon.cacicedofernandezbobadilla@osakidetza.net.
² Cruces University Hospital, Radiation Oncology Department, c/Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya (Basque Country), Spain. Electronic address: Pedro.bilbaozulaica@osakidetza.net.

No abstract available

Comment on

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Lartigau EF, Tresch E, Thariat J, Graff P, Coche-Dequeant B, Benezery K, Schiappacasse L, Degardin M, Bondiau PY, Peiffert D, Lefebvre JL, Lacornerie T, Kramar A. Lartigau EF, et al. Radiother Oncol. 2013 Nov;109(2):281-5. doi: 10.1016/j.radonc.2013.08.012. Epub 2013 Nov 18. Radiother Oncol. 2013. PMID: 24262821 Clinical Trial.